{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T01:49:51Z","timestamp":1658713791873},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Natl Compr Canc Netw"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.6004\/jnccn.2014.0160","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T12:04:33Z","timestamp":1492171473000},"page":"1615-1620","source":"Crossref","is-referenced-by-count":1,"title":["Where Exactly Does Ponatinib Fit in Chronic Myelogenous Leukemia?"],"prefix":"10.6004","volume":"12","author":[{"given":"Ellin","family":"Berman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","published-online":{"date-parts":[[2014,10,31]]},"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T12:10:59Z","timestamp":1551701459000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/doi\/10.6004\/jnccn.2014.0160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":0,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,10,31]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.6004\/jnccn.2014.0160"],"URL":"https:\/\/doi.org\/10.6004\/jnccn.2014.0160","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]}}}